Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - P/B ratio
P/B ratio as of May 2024 : 2.45
According to Agios Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Agios Pharmaceuticals - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.53 | 9.5% |
| 2022-12-31 | 1.40 | 1.44% |
| 2021-12-31 | 1.38 | -81.61% |
| 2020-12-31 | 7.51 | 47.32% |
| 2019-12-31 | 5.10 | 30.6% |
| 2018-12-31 | 3.90 | -47.4% |
| 2017-12-31 | 7.42 | 51.82% |
| 2016-12-31 | 4.89 | -31.05% |
| 2015-12-31 | 7.09 | -27.61% |
| 2014-12-31 | 9.80 | 72.34% |
| 2013-12-31 | 5.68 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.84 | -25.09% | 🇺🇸 USA |
 Eli Lilly LLY | 56.8 | 2,219.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.54 | 125.94% | 🇬🇧 UK |
 Xencor XNCR | 2.07 | -15.52% | 🇺🇸 USA |
 Exelixis EXEL | 2.91 | 18.61% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 2.88 | 17.57% | 🇺🇸 USA |